60
ASAA
Martins HAL, Martins BBM, Santos CC, Pontes J, Oliveira DA, Valença MM
Persistent idiopathic facial pain associated with borderline personality disorder: a case report
Introduction
P
ersistent idiopathic facial pain (PIFP) is a chronic disease of
unknown etiology. Patients usually complain of unilateral pain
affecting the maxillary region, usually described as burning, pul-
sating, profound, or painful. However, as described in Figure 1,
PIFP neither meet criteria for neuralgia nor present objective signs of
neurological changes on imaging or clinical examination or dental
causes after a detailed investigation.
1
Furthermore, few controlled
studies demonstrated these patients might present a poor clinical
response to antidepressant use (e.g., amitriptyline and nortriptyline)
and improved quality of life when associated with psychotherapy.
2
Association of PIFP and depression, anxiety symptoms, and poor
quality of life are well documented in previous studies, although only
a few studies about personality traits were performed.
2,3
A. Facial and/or oral pain fullling criteria B and C.
B. Recurring daily for >2 hours/day >3 months.
C. Pain has both of the following characteristics:
1. Poorly localized and not following distribution of peripheral nerve.
2. Dull, aching, or nagging quality.
D. Clinical neurological examination is normal.
E. Dental cause has been excluded by appropriate investigations.
F. Not better accounted for by another ICHD -3 diagnosis.
Figure 1. Persistent idiopathic facial pain diagnostic criteria (ICHD-3)
A set of stable individual characteristics (i.e., specic functioning
patterns) is formed by a set of stable individual characteristics
with a personal manner of perceiving oneself, other people, and
life events.
4
However, a personality disorder might be present
when this pattern is rigid, pervasive, inexible, and maladaptive.
Personality disorders affect approximately 10% of the population,
with borderline personality disorder (BPD) corresponding to half
of this content.
5
Among all personality disorders, BPD is the most related to painful
syndromes.
6
Table 1 shows the
Diagnostic and Statistical Manual
of Mental Disorders
(DSM-5) diagnostic criteria for BPD (ve out of
nine criteria are required for diagnosis). BPD is characterized by
severe changes in cognition, emotion, behavior, and interpersonal
relationships. Self-injurious behaviors are frequent, such as hair
pulling, slapping, throwing on the oor, hitting head on the wall,
cutting, or scratching. Non-lethal attempt methods sometimes
follow suicidal ideation (e.g., excessive medication-taking at once)
or violent methods, such as hanging, jumping from high places,
throwing themselves in front of automobiles at high speed, and
self-harm with knives or rearms.
6-8
Studies observed a 30% prevalence rate of BPD among patients
with chronic pain. Pain scores are higher in patients with chronic
pain and BPD than those patients without BPD.
6
One study
evaluated 777 patients undergoing pain rehabilitation and
observed more pain complaints in those with BPD.
9
In a study
evaluating patients with BPD found more painful syndromes (e.g.,
lumbar pain, temporomandibular joint [TMJ] disorders, and
bromyalgia) in patients with active BPD symptoms than patients
with remission of BPD symptoms.
10
Table 1 Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnostic
criteria for borderline personality disorder
1. Frantic efforts to avoid real or imagined abandonment (Note: Do not
include suicidal or self-mutilating behavior covered in Criterion 5);
2. Pattern of unstable and intense interpersonal relationships characterized by
alternating between extremes of idealization and devaluation;
3. Identity disturbance: markedly and persistently unstable self-image or sense
of self;
4. Impulsivity in at least two areas that are potentially self-damaging (e.g.,
spending, sex, substance abuse, reckless driving, binge eating) (Note: Do not
include suicidal or self-mutilating behavior covered in Criterion 5);
5. Recurrent suicidal behavior, gestures, threats, or self-mutilating behavior;
6. Affective instability due to a marked reactivity of mood (e.g., intense episodic
dysphoria, irritability, or anxiety usually lasting a few hours and only rarely
more than a few days);
7. Chronic feelings of emptiness;
8. Inappropriate, intense anger or difculty controlling anger (e.g., frequent
displays of temper, constant anger, recurrent physical ghts);
9. Transient, stress-related paranoid ideation or severe dissociative symptoms.
Clinical observations showed that patients with BPD are more
intolerant to chronic pain.
11
Brain imaging studies in BPD
demonstrated top-down dysregulation in emotional control
12
inuencing chronic pain signaling.
7,12
Some neural structures in
the fronto-limbic region are also altered in BPD. Studies using
functional magnetic resonance imaging demonstrated increased
amygdala reactivity and reduced activity in the prefrontal cortex
and anterior area of the cingulate gyrus, regions involved in
abnormal pain processing.
9
Therefore, this study aims to report a patient with PIFP and BPD
who did not respond to treatments before BPD diagnosis and
showed good clinical evolution after proper psychotherapeutic
BPD management associated with psychopharmacological
treatment for mood stabilization.
Case report
This study was conducted at the Brain Unity Clinic in Surubim-PE
(Brazil) and approved by the human research ethics committee
(protocol number 464456921.4.000.5640). This case report
concerns a 24-year-old woman with a history of severe pain on
the left side of the face for ten months. She reported diffuse pain
without specic exacerbation points lasting three to six hours, ve
days per week. She denied dental procedures before pain onset
and attended several dental evaluations because she believed it
could be a dental problem. TMJ imaging by magnetic resonance
(MRI) and arthroscopy showed nonspecic changes and did not
elucidate the cause of pain. She was also evaluated and treated
by a neurologist, who did not encounter any abnormalities after
a detailed neurological examination of facial sensitivity. Brain
MRI was also normal. She used daily 50 mg of amitriptyline,
carbamazepine (600 mg), and gabapentin (900 mg) during
previous treatments.